Clinical Trials Browser

INDUSTRY × Interventional × Tinnitus × Clear all

NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Phase 2 Withdrawn

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT01549145 2012-08-29

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

Phase NA Completed

Lymphoma, Follicular, Tinnitus